HOME › DRUGS › ALPELISIB
ACTIVE SUBSTANCE / INN

ALPELISIB

Brand name(s): Piqray, VIJOICE, PIQRAY, Vijoice
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
AUTHORISED
Breast Neoplasms
NDA218466
ACTIVE SUBSTANCE
Alpelisib
REGULATORS
FDA · EMA
SPONSORS / MAH
NOVARTIS, Novartis Europharm Limited
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VIJOICENDA218466NOVARTISPrescription
PIQRAYNDA212526NOVARTISPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PiqrayNovartis Europharm LimitedAuthorised27/07/2020Breast Neoplasms
VijoiceNovartis Europharm LimitedApplication withdrawnGenetic Diseases, Inborn;Growth Disorders

FULL INTELLIGENCE ON ALPELISIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →